[ACE inhibitors and kidney].
One of the major challenges for today's nephrology is to elucidate the mechanism of action of ACE-inhibitors in damaged kidneys. Clarification of the mechanisms involved will not only increase the understanding of the pathomechanisms involved in progression, but also enrich the therapeutic armamentarium available to the nephrologist.
Ritz
E
E
Medizinische Universitätsklinik, Heidelberg, BRD.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003928:Diabetic Nephropathies / Q000188:drug therapy; D004656:Enalapril / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000503:physiopathology
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril
ACE-Hemmer und Niere.